Andover National Corp Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2021-12-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2021-12-31..
- Interest coverage · 12 months: Value -105.63×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2021-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2021-12-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2021-12-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | -105.63× | Operating income ÷ reported interest expense. $-11.92M ÷ $112.88K ≈ -105.63× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 18.69M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -11.92M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 112.88K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | (m) | $18.69M | (m) | $-11.92M | $112.88K | (m) | (m) | -105.63× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $7.70M | (m) | $-3.35M | $7.22K | (m) | (m) | -463.14× | Reported |
| 2020-09-30 | (m) | $6.16M | (m) | $-3.79M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-10-03 | (m) | (m) | (m) | $919.49K | $-16.58K | (m) | (m) | (m) | Reported |
| 2019-09-30 | (m) | (m) | (m) | $919.49K | $-16.58K | (m) | (m) | (m) | Reported |
| 2019-06-30 | (m) | (m) | (m) | $687.87K | $-10.08K | (m) | (m) | (m) | Reported |
| 2019-03-31 | (m) | (m) | (m) | $586.48K | $-4.83K | (m) | (m) | (m) | Reported |
| 2018-12-31 | (m) | $2.24M | (m) | $433.88K | $1.12K | (m) | (m) | 386.70× | Reported |
| 2018-09-30 | (m) | $37.61K | (m) | $-185.81K | $24.25K | (m) | (m) | -7.66× | Reported |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $39.83K | $680.00 | $-59.88K | $25.12K | (m) | 1.71% | -2.38× | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.